Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.397

Obesity Related Adipokines and Colorectal Cancer: A Review and Meta-Analysis  

Joshi, Rakhi Kumari (Department of Preventive Medicine, Kangwon National University School of Medicine)
Lee, Sang-Ah (Department of Preventive Medicine, Kangwon National University School of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 397-405 More about this Journal
Abstract
Obesity has been considered as an important risk factor for the development of colorectal cancer (CRC), but the association has not been fully elucidated. Obesity is linked significantly to adipose tissue dysfunction and to alteration of adipokines in blood; in particular, obesity-induced inflammation is thought to be an important link between obesity and colorectal cancer. Based on epidemiological studies, we undertook a systematic review to understand the association of circulating levels of selected adipokines, including adiponectin, leptin, resistin, IL-6 and TNF-${\alpha}$, with the level of CRC risk. Most prospective studies suggested protective effects of adiponectin, but these were attenuated by body mass index (BMI) and waist circumference (WC) data in our meta-analysis. On the other hand, meta-analyses for leptin and CRC did not demonstrate any association, similar to the results of systematic review. Although it proved difficult to determine whether other selected adipokines (resistin, IL-6 and TNF-${\alpha}$) were related to CRC risk due to small number of reports, the present systematic review suggested a positive association with elevated resistin levels but null associations with IL-6 and TNF-${\alpha}$.
Keywords
Adipokines; colorectal cancer; obese-related adipokines; obesity; risk factors;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Tamakoshi K, Toyoshima H, Wakai K, et al (2005). Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncol, 68, 454-61.   DOI   ScienceOn
2 Tilg H, Moschen AR (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature reviews Immunol, 6, 772-83.   DOI   ScienceOn
3 Touvier M, Fezeu L, Ahluwalia N, et al (2012). Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World J Gastroenterol, 18, 2805-12.   DOI   ScienceOn
4 Wei EK, Giovannucci E, Fuchs CS, et al (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94.   DOI   ScienceOn
5 Roberts DL, Dive C, Renehan AG (2010). Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med, 61, 301-16.   DOI   ScienceOn
6 Pais R, Silaghi H, Silaghi AC, et al (2009). Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol, 15, 5141-8.   DOI
7 Paz-Filho G, Lim EL, Wong ML, Licinio J (2011). Associations between adipokines and obesity-related cancer. Front Biosci (Landmark Ed), 16, 1634-50.   DOI
8 Reilly MP, Lehrke M, Wolfe ML, et al (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111, 932-9.   DOI   ScienceOn
9 Salageanu A, Tucureanu C, Lerescu L, et al (2010). Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life, 3, 416-20.
10 Sierra-Honigmann MR, Nath AK, Murakami C, et al (1998). Biological action of leptin as an angiogenic factor. Science, 281, 1683-6.   DOI   ScienceOn
11 Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM, Boon L (2005). Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1betatreated human preadipocytes are potent leptin producers. Cytokine, 32, 94-103.   DOI   ScienceOn
12 Stattin P, Lukanova A, Biessy C, et al (2004). Obesity and colon cancer: does leptin provide a link? Int J Cancer, 109, 149-52.   DOI   ScienceOn
13 Stattin P, Palmqvist R, Soderberg S, et al (2003). Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep, 10, 2015-21.
14 Stocks T, Lukanova A, Johansson M, et al (2008). Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond), 32, 304-14.   DOI
15 Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006). Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 15, 401-2.   DOI   ScienceOn
16 Moghaddam AA, Woodward M and Huxley R (2007). Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev, 16, 2533-47.   DOI   ScienceOn
17 Larsson SC, Wolk A (2007). Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr, 86, 556-65.
18 Lotem J, Sachs L (1998). Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. Proc Natl Acad Sci U S A, 95, 4601-6.   DOI
19 Mantel N & Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
20 Nagaev I & Smith U (2001). Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun, 285, 561-4.   DOI   ScienceOn
21 Nakajima TE, Yamada Y, Hamano T, et al (2010). Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 101, 1286-91.   DOI   ScienceOn
22 Ning Y, Wang L, Giovannucci EL (2010). A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev, 11, 19-30.   DOI   ScienceOn
23 Otake S, Takeda H, Fujishima S, et al (2010). Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol, 16, 1252-7.   DOI   ScienceOn
24 Kemik O, Sumer A, Kemik AS, et al (2010). The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol, 8, 85.   DOI   ScienceOn
25 Kern PA, Ranganathan S, Li C, et al (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab, 280, 745-51.
26 Ho GY, Wang T, Gunter MJ, et al (2012). Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res, 72, 3029-37.   DOI
27 Il'yasova D, Colbert LH, Harris TB, et al (2005). Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev, 14, 2413-8.   DOI   ScienceOn
28 Kawanami D, Maemura K, Takeda N, et al (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokineendothelial cell interactions. Biochem Biophys Res Commun, 314, 415-9.   DOI   ScienceOn
29 Knupfer H, Preiss R (2010). Serum interleukin-6 levels in colorectal cancer patients a summary of published results. Int J Colorectal Dis, 25, 135-40.   DOI
30 Kubota N, Terauchi Y, Yamauchi T, et al (2002). Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 277, 25863-6.   DOI   ScienceOn
31 Kumada M, Kihara S, Ouchi N, et al (2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 109, 2046-9.   DOI   ScienceOn
32 Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-81.   DOI   ScienceOn
33 Fruhbeck G (2006). Intracellular signalling pathways activated by leptin. Biochem J, 393, 7-20.   DOI   ScienceOn
34 Gialamas SP, Petridou ET, Tseleni-Balafouta S, et al (2011). Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism, 60, 1530-8.   DOI   ScienceOn
35 Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol Pract, 115, 911-9.   DOI   ScienceOn
36 Fernandez-Real JM, Ricart W (2003). Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev, 24, 278-301.   DOI   ScienceOn
37 Friedman JM, Halaas JL (1998). Leptin and the regulation of body weight in mammals. Nature, 395, 763-70.   DOI   ScienceOn
38 Gialamas SP, Sergentanis TN, Antonopoulos CN, et al (2013). Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis. Cancer Causes Control, 24, 2129-41.   DOI   ScienceOn
39 Gonullu G, Kahraman H, Bedir A, et al (2010). Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis, 25, 205-12.   DOI   ScienceOn
40 Gs HJ (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [update March 2011]. The Cochrane Collabration 2011.
41 Gunter MJ, Hoover DR, Yu H, et al (2008). Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res, 68, 329-37.   DOI   ScienceOn
42 Heikkila K, Harris R, Lowe G, et al (2009). Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a metaanalysis. Cancer Causes Control, 20, 15-26.   DOI   ScienceOn
43 Cochran W (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.   DOI   ScienceOn
44 Considine RV, Sinha MK, Heiman ML, et al (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med, 334, 292-5.   DOI   ScienceOn
45 Chan AT, Ogino S, Giovannucci EL, Fuchs CS (2011). Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterol, 140, 799-808.   DOI   ScienceOn
46 Chen MW, Ye S, Zhao LL, et al (2012). Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol, 29, 3129-35.   DOI   ScienceOn
47 Cottam DR, Mattar SG, Barinas-Mitchell E, et al (2004). The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg, 14, 589-600.   DOI   ScienceOn
48 Dai Z, Xu YC, Niu L (2007). Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol, 13, 4199-206.
49 Danese E, Montagnana M, Minicozzi AM, et al (2012). The role of resistin in colorectal cancer. Clin Chim Acta, 413, 760-4.   DOI   ScienceOn
50 Dersimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI   ScienceOn
51 Eder K, Baffy N, Falus A, Fulop AK (2009). The major inflammatory mediator interleukin-6 and obesity. Inflamm Res, 58, 727-36.   DOI   ScienceOn
52 Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI   ScienceOn
53 Aleksandrova K, Boeing H, Jenab M, et al (2012). Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort. Cancer Res, 72, 5328-37.   DOI   ScienceOn
54 Erarslan E, Turkay C, Koktener A, et al (2009). Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci, 54, 862-8.   DOI
55 Aleksandrova K, Nimptsch K, Pischon T (2013). Influence of obesity and related metabolic alterations on colorectal cancer risk. Current nutrition reports, 2, 1-9.   DOI   ScienceOn
56 Yokota T, Oritani K, Takahashi I, et al (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96, 1723-32.
57 An W, Bai Y, Deng SX, et al (2012). Adiponectin levels in patients with colorectal cancer and adenoma: a metaanalysis. Eur J Cancer Prev, 21, 126-33.   DOI
58 Arpaci F, Yilmaz MI, Ozet A, et al (2002). Low serum leptin level in colon cancer patients without significant weight loss. Tumori, 88, 147-9.
59 Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86, 858-66.
60 Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101.   DOI   ScienceOn
61 Bokarewa M, Nagaev I, Dahlberg L, et al (2005). Resistin, an adipokine with potent proinflammatory properties. J Immunol, 174, 5789-95.   DOI
62 Aleksandrova K, Boeing H, Jenab M, et al (2012). Total and high-molecular weight adiponectin and risk of colorectal cancer: the European prospective investigation into cancer and nutrition study. Carcinogenesis, 33, 1211-8.   DOI   ScienceOn
63 Wolf AM, Wolf D, Rumpold H, et al (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun, 323, 630-5.   DOI   ScienceOn
64 Xu XT, Xu Q, Tong JL, et al (2011). Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis, 12, 234-44.   DOI   ScienceOn
65 Yamauchi T, Kamon J, Minokoshi Y, et al (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8, 1288-95.   DOI   ScienceOn
66 Lee S, Choe JW, Kim HK, Sung J (2011). High-sensitivity C-reactive protein and cancer. J Epidemiol, 21, 161-8.   DOI
67 Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8.   과학기술학회마을   DOI   ScienceOn